drugset / Trial / NCT06236841
A Phase I Study of XH-S004 in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a phase I, randomised, double-blind placebo-controlled, 3-part study to assess the safety, tolerability, pharmacokinetics and food effect of single and multiple oral doses of XH-S004 in healthy volunteers.
Timeline
- Start
- 2024-01-26
- Primary completion
- 2025-01-31
- Completion
- 2025-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | XH-S004 | Unknown | 5 mg | Oral |
Indications
No indication recorded.